Your browser doesn't support javascript.
loading
Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.
Johnson, Paul C D; McAulay, Karen A; Montgomery, Dorothy; Lake, Annette; Shield, Lesley; Gallagher, Alice; Little, Ann-Margaret; Shah, Anila; Marsh, Steven G E; Taylor, G Malcolm; Jarrett, Ruth F.
Afiliación
  • Johnson PC; Boyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom.
  • McAulay KA; MRC - University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Montgomery D; MRC - University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Lake A; MRC - University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Shield L; MRC - University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Gallagher A; MRC - University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Little AM; Histocompatibility and Immunogenetics Laboratory, Gartnavel General Hospital, Glasgow, United Kingdom.
  • Shah A; Anthony Nolan, Royal Free Hospital, Hampstead, London, United Kingdom.
  • Marsh SG; Anthony Nolan, Royal Free Hospital, Hampstead, London, United Kingdom.
  • Taylor GM; Cancer Institute, University College London, Royal Free Campus, London, United Kingdom.
  • Jarrett RF; Immunogenetics Group, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Int J Cancer ; 137(5): 1066-75, 2015 Sep 01.
Article en En | MEDLINE | ID: mdl-25648508
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Antígenos de Histocompatibilidad Clase I / Antígenos de Histocompatibilidad Clase II / Infecciones por Virus de Epstein-Barr / Polimorfismo de Nucleótido Simple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Antígenos de Histocompatibilidad Clase I / Antígenos de Histocompatibilidad Clase II / Infecciones por Virus de Epstein-Barr / Polimorfismo de Nucleótido Simple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido